SageGuard Financial Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$213K Sell
8,858
-919
-9% -$24K 0.03% 203
2026
Q1
$275K Buy
9,777
+199
+2% +$5.3K 0.04% 165
2025
Q4
$238K Buy
+9,578
New +$242K 0.04% 159
2021
Q3
Sell
-70,631
Closed -$2.77M 98
2021
Q2
$2.77M Buy
70,631
+1,060
+2% +$41.2K 1.26% 21
2021
Q1
$2.53M Sell
69,571
-17,039
-20% -$605K 1.18% 20
2020
Q4
$3.18M Buy
+86,610
New +$3.18M 1.53% 15

Other funds holding PFE

SageGuard Financial Group's PFE Position: Q2 2026 in Review

SageGuard Financial Group reduced its Pfizer (PFE) stake by 9.4% in Q2 2026, selling an estimated $24K and leaving 8,858 shares worth $213K. The position accounts for 0.03% of the portfolio, ranked #203.

SageGuard Financial Group first reported a position in PFE in Q4 2020 and has held it in 6 quarters since. The position peaked at $3.18M in Q4 2020. 1,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • SageGuard Financial Group held 8,858 shares of Pfizer worth $213K as of Q2 2026.
  • SageGuard Financial Group sold 919 Pfizer shares in Q2 2026, an estimated $24K.
  • Pfizer made up 0.03% of SageGuard Financial Group's portfolio in Q2 2026, its #203 holding.
  • SageGuard Financial Group first reported a position in Pfizer in Q4 2020 and has held it in 6 quarters since.
  • SageGuard Financial Group's Pfizer position peaked at $3.18M in Q4 2020.
  • 1,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on SageGuard Financial Group's 13F filing for Q2 2026, filed 27 Jul 2026.